Malaria Reduction (IMAGE) Scripps Research Institute Caption Predicted impact of mass administration of an isoxazoline drug on malaria incidence in Africa. The figure shows cumulative reduction in incidence during 2 years of fluralaner/afoxolaner mass drug administration covering 30 percent of the population over the age of 5, dosed once per year optimally timed in relation to the start of the transmission season. Credit Image by Calibr/ TropIQ Health Sciences Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.